05/07/2024
3:06 PM | Aclaris Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/25/2024
6:00 AM | Aclaris Therapeutics (Filer)
| Form DEF 14A | |
04/25/2024
6:01 AM | Aclaris Therapeutics (Filer)
| Form DEFA14A | |
04/25/2024
6:02 AM | Aclaris Therapeutics (Filer)
| Form ARS | |
04/03/2024
4:00 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
4:08 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
|
02/27/2024
6:14 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
7:32 PM | Aclaris Therapeutics (Subject)
Venrock Healthcare Capital Partners II, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
9:30 AM | Aclaris Therapeutics (Subject)
BIOTECHNOLOGY VALUE FUND L P (Filed by)
| Form SC 13G/A | |
02/13/2024
1:24 PM | Aclaris Therapeutics (Subject)
Foresite Capital Fund IV, L.P. (Filed by)
| Form SC 13G/A | |
02/08/2024
10:14 AM | Aclaris Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G/A | |
02/08/2024
9:47 AM | Aclaris Therapeutics (Issuer)
Leonard Braden Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/05/2024
6:29 PM | Aclaris Therapeutics (Issuer)
Loerop James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:31 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:36 PM | Aclaris Therapeutics (Issuer)
Walker Neal (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
6:27 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:31 PM | Aclaris Therapeutics (Filer)
| Form 8-K/A | |
01/19/2024
6:30 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
4:24 PM | Aclaris Therapeutics (Subject)
BML Investment Partners, L.P. (Filed by)
| Form SC 13G | |
12/11/2023
3:25 PM | Aclaris Therapeutics (Subject)
MILLENNIUM MANAGEMENT LLC (Filed by)
| Form SC 13G | |
12/11/2023
8:36 AM | Aclaris Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/24/2023
12:49 PM | Aclaris Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
11/13/2023
6:42 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2023
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2023
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/25/2023
3:28 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2023
3:06 PM | Aclaris Therapeutics (Subject)
Monahan Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023
7:00 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/07/2023
3:16 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
4:08 PM | Aclaris Therapeutics (Issuer)
Balthaser Kevin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:14 PM | Aclaris Therapeutics (Subject)
CITADEL ADVISORS LLC (Filed by)
| Form SC 13G | |
08/28/2023
3:39 PM | Aclaris Therapeutics (Issuer)
Loerop James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2023
3:31 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/21/2023
3:20 PM | Aclaris Therapeutics (Subject)
Monahan Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2023
6:15 AM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
6:30 AM | Aclaris Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/22/2023
3:30 PM | Aclaris Therapeutics (Issuer)
Monahan Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/22/2023
3:32 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:31 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:31 PM | Aclaris Therapeutics (Subject)
Monahan Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Tech GIANT’s Plans to Revolutionize Crypto… (Ad) A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.
If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…
The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
 Claim your free seat by clicking here now. |
06/12/2023
3:15 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2023
4:02 PM | Aclaris Therapeutics (Issuer)
Molineaux Christopher P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
4:04 PM | Aclaris Therapeutics (Issuer)
GOWEN MAXINE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:53 PM | Aclaris Therapeutics (Issuer)
SCHIFF ANDREW N (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:57 PM | Aclaris Therapeutics (Issuer)
Reasons Bryan M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:45 PM | Aclaris Therapeutics (Issuer)
Mehra Anand (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2023
3:50 PM | Aclaris Therapeutics (Issuer)
Powell Andrew Kenneth William (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/01/2023
3:18 PM | Aclaris Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
